Skip to main content
SpringerLink
Log in

DHA, EPA, and Ocular Health

  • Chapter
  • First Online:
Omega-6/3 Fatty Acids

Part of the book series: Nutrition and Health ((NH))

  • 2815 Accesses

Abstract

The eyes and visual system often get overlooked when the medical practitioner considers chronic disease. This might be due to the fact that the eyes and their study is a very specialized field or that the eyes are considered normal if the person can see clearly. Either way, it is becoming more known that the eye is not simply a window to the soul but actually is a mirror of the body.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 239.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 239.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Tomlinson A. Epidemiology of dry eye disease. In: Asbell P, Lemp MA, editors. Dry eye disease: the clinician’s guide to diagnosis and treatment. New York, NY: Thieme; 2006. p. 1–15.

    Google Scholar 

  2. Moss SE, Klein R, Klein B. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol. 2000;118:1264–8.

    Article  PubMed  CAS  Google Scholar 

  3. Allergan, Inc. survey conducted online in the United States March 4–8, 2011, among 2,411 adults (age 18 and older) by Harris Interactive on behalf of Allergan, Inc., via its Quick Query omnibus product.

    Google Scholar 

  4. Dry Eye Fact Sheet. Accessible at: http://www.schepens.harvard.edu/dry_eye_fact_sheet.htm. Accessed 15 Jan 2012.

  5. Sullivan BD, Whitmer D, Nichols KK, et al. An objective approach to dry eye disease severity. Invest Ophthalmol Vis Sci. 2010;51(12):6125–30.

    Article  PubMed  Google Scholar 

  6. Lemp MA, Bron AJ, Baudouin C, et al. Tear osmolarity in the diagnosis and management of dry eye disease. Am J Ophthalmol. 2011;151(5):792–8.

    Article  PubMed  Google Scholar 

  7. Rolando M, Lester M, Macrí A, Calabria G. Low spatial contrast sensitivity in dry eyes. Cornea. 1998;17:376–9.

    Article  PubMed  CAS  Google Scholar 

  8. Akin T, Karadayi K, Aykan U, et al. The effects of artificial tear application on contrast sensitivity in dry and normal eyes. Eur J Ophthalmol. 2006;16(6):785–90.

    PubMed  CAS  Google Scholar 

  9. Goto E, Yagi Y, Matsumoto Y, et al. Impaired functional visual acuity of dry eye patients. Am J Ophthalmol. 2002;133(2):181–6.

    Article  PubMed  Google Scholar 

  10. Albarrán C, Pons AM, Lorente A, et al. Influence of the tear film on optical quality of the eye. Cont Lens Anterior Eye. 1997;20(4):129–35.

    Article  PubMed  Google Scholar 

  11. Szodoray P, Hovath IF, Papp G, et al. The immunoregulatory role of vitamins A, D and E in patients with primary Sjogren’s syndrome. Rheumatology. 2010;49(2):211–7.

    Article  PubMed  CAS  Google Scholar 

  12. Wu D, Meydani M, Leka LS, et al. Effect of dietary supplementation with black currant seed oil on the immune response of healthy elderly subjects. Am J Clin Nutr. 1999;70:536–43.

    PubMed  CAS  Google Scholar 

  13. Horrobin DF, Campbell A. Sjogren’s syndrome and the sicca syndrome: the role of prostaglandin E1 deficiency. Treatment with essential fatty acids and vitamin C. Med Hypotheses. 1980;6(3):225–32.

    Article  PubMed  CAS  Google Scholar 

  14. Jiang Q, Elson-Schwab I, Courtemanche C, Ames BN. Gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclo-oxygenase activity in macrophages and epithelial cells. Proc Natl Acad Sci USA. 2000;97(21):11494.

    Article  PubMed  CAS  Google Scholar 

  15. Plummer SM, Holloway KA, Manson MM, et al. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappa B activation via the NIK/IKK signaling complex. Oncogene. 1999;18(44):6013–20.

    Article  PubMed  CAS  Google Scholar 

  16. Tei M, Spun-Michaid SJ, Tisdale AS, et al. Vitamin A deficiency alters the expression of mucin genes by the rat ocular surface epithelium. Invest Ophthalmol Vis Sci. 2000;41(1):82–8.

    PubMed  CAS  Google Scholar 

  17. Stern ME, Beuerman RW, Fox RI, et al. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea. 1998;17:584–9.

    Article  PubMed  CAS  Google Scholar 

  18. Solomon A, Dursun D, Pflugfelder SC. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci. 2001;42(10):2283–92.

    PubMed  CAS  Google Scholar 

  19. Barabino S, Rolando M, Camicione P, et al. Systemic linoleic and gamma-linolenic acid therapy in dry eye syndrome with an inflammatory component. Cornea. 2003;22(2):97–101.

    Article  PubMed  Google Scholar 

  20. Johnson MM, Swan DD, Surette ME, et al. Dietary supplementation with gamma-linolenic acid alters fatty acid content and eicosanoid production in healthy humans. J Nutr. 1997;127(8):1435–44.

    PubMed  CAS  Google Scholar 

  21. Volker D, Fitzgerald P, Major G, et al. Efficacy of fish oil concentrate in the treatment of rheumatoid arthritis. J Rheumatol. 2000;27:2343–6.

    PubMed  CAS  Google Scholar 

  22. Barham JB, Edens MB, Fonteh AN, et al. Addition of eicosapentaenoic acid to gamma-linolenic acid-supplemented diets prevent serum arachidonic acid accumulation in humans. J Nutr. 2000;130(8):1925–31.

    PubMed  CAS  Google Scholar 

  23. Rosenberg ES, Asbell PA. Essential fatty acids in the treatment of dry eye. Ocul Surf. 2010;8(1):18–28.

    Article  PubMed  Google Scholar 

  24. Viau S, Maire MA, Pasquis B, et al. Efficacy of a 2-month dietary supplementation with polyunsaturated fatty acids in dry eye induced by scopolamine in a rat model. Graefes Arch Clin Exp Ophthalmol. 2009;247(8):1039–50.

    Article  PubMed  CAS  Google Scholar 

  25. He J, Bazan HE. Omega-3 fatty acids in dry eye and corneal nerve regeneration after refractive surgery. Prostaglandins Leukot Essent Fatty Acids. 2010;82(4–6):319–25.

    Article  PubMed  CAS  Google Scholar 

  26. Li N, He J, Schwartz CE, et al. Resolvin E1 improves tear production and decreases inflammation in a dry eye mouse model. J Ocul Pharmacol Ther. 2010;26(5):431–9.

    Article  PubMed  Google Scholar 

  27. Cortina MS, Bazan HE. Docosahexaenoic acid, protectins and dry eye. Curr Opin Clin Nutr Metab Care. 2011;14(2):132–7.

    Article  PubMed  CAS  Google Scholar 

  28. Wojtowicz JC, Butovich I, Uchiyama E, et al. Pilot, prospective, randomized, double-masked, placebo-controlled clinical trial of an omega-3 supplement for dry eye. Cornea. 2011;30(3):308–14.

    Article  PubMed  Google Scholar 

  29. Tzen J, Cao Y, Laurant C, et al. Lipids, proteins, and structure of seed oil bodies from diverse species. Plant Physiol. 1993;101(1):267–76.

    PubMed  CAS  Google Scholar 

  30. Cai J, Nelson KC, Wu M, et al. Oxidative damage and protection of the RPE. Prog Retin Eye Res. 2000;19(2):205–21.

    Article  PubMed  CAS  Google Scholar 

  31. Leibovitz BE, Siegel BV. Aspects of free radical reactions in biological systems: aging. J Gerontol. 1980;35(1):45–56.

    Article  PubMed  CAS  Google Scholar 

  32. Liles MR, Newsome DA, Oliver PD. Antioxidant enzymes in the aging human retinal pigment epithelium. Arch Ophthalmol. 1991;109:1285–8.

    Article  PubMed  CAS  Google Scholar 

  33. Grahn BH, Paterson PG, et al. Zinc and the eye. J Am Coll Nutr. 2001;20(2 Suppl):106–18.

    PubMed  CAS  Google Scholar 

  34. Tate DJ, Miceli MV, Newsome DA, et al. Influence of zinc on selected cellular functions of cultured human retinal pigment epithelium. Curr Eye Res. 1995;14(10):897–903.

    Article  PubMed  CAS  Google Scholar 

  35. Wyszynski R, Burner W, Cano D, et al. A donor-age-dependent change in the activity of alpha-mannosidase in human cultured RPE cells. Invest Ophthalmol Vis Sci. 1989;30:2341–7.

    PubMed  CAS  Google Scholar 

  36. Tate Jr DJ, Miceli MV, Newsome DA. Zinc protects against oxidative damage in cultured human retinal pigment epithelial cells. Free Radic Biol Med. 1999;26(5–6):704–13.

    Article  PubMed  CAS  Google Scholar 

  37. NIH Office of Dietary Supplements Vitamin C fact sheet.Ods.od.nih.gov/factsheets/vitaminC/?print=1. Accessed 12 Feb 2012.

  38. Burton GW, Traber MG. Vitamin E: antioxidant activity, biokinetics, and bioavailability. Annu Rev Nutr. 1990;10:357–82.

    Article  PubMed  CAS  Google Scholar 

  39. Whitehead AJ, Mares JA, Danis RP. Macular pigment: a review of current knowledge. Arch Ophthalmol. 2006;124(7):1038–45.

    Article  PubMed  CAS  Google Scholar 

  40. Richer S. LAST II: differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls. Optometry. 2007;78:213–9.

    Article  PubMed  Google Scholar 

  41. Trieschmann M, Beatty S, Nolan JM, et al. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study. Exp Eye Res. 2007;84(4):718–28.

    Article  PubMed  CAS  Google Scholar 

  42. European Food Safety Authority (EFSA). Scientific opinion on the substantiation of health claims related to docosahexaenoic acid (DHA). EFSA J. 2011;8(10):1734.

    Google Scholar 

  43. AREDS2 is a multi-center phase III randomized clinical trial designed to access the effects of oral supplementation of high doses of macular xanthophylls (lutein and zeaxanthin) and/or omega-3 long-chain polyunsaturated fatty acids (LCPUFAs) as a treatment for age-related macular degeneration (AMD), cataract and moderate vision loss.

    Google Scholar 

  44. Nolan JM, Stack J, O’Donovan O, et al. Risk factors for age-related maculopathy are associated with a relative lack of macular pigment. Exp Eye Res. 2007;84(1):61–74.

    Article  PubMed  CAS  Google Scholar 

  45. Hageman GS, Luthert PJ, Victor Chong NH, et al. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch’s membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res. 2001;20:705–32.

    Article  PubMed  CAS  Google Scholar 

  46. Anderson DH, Mullins RF, Hageman GS, et al. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol. 2002;134:411–31.

    Article  PubMed  CAS  Google Scholar 

  47. Bok D. Evidence for an inflammatory process in age-related macular degeneration gains new support. Proc Natl Acad Sci U S A. 2005;102:7053–4.

    Article  PubMed  CAS  Google Scholar 

  48. Hageman GS, Anderson DH, Johnson LV, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA. 2005;102:7227–32.

    Article  PubMed  CAS  Google Scholar 

  49. Haines JL, Hauser MA, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005;308:419–21.

    Article  PubMed  CAS  Google Scholar 

  50. Spencer KL, Hauser MA, Olson LM, et al. Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration. Hum Mol Genet. 2007;16:1986–92.

    Article  PubMed  CAS  Google Scholar 

  51. Yates JR, Sepp T, Matharu BK, et al. Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med. 2007;357:553.

    Article  PubMed  CAS  Google Scholar 

  52. Wang AL, Lukas TJ, Yuan M, et al. Autophagy and exosomes in the aged retinal pigment epithelium: possible relevance to drusen formation and age-related macular degeneration. PLoS One. 2009;4:e4160.

    Article  PubMed  Google Scholar 

  53. SanGiovanni JP, Chew EY, Clemons TE, et al. The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22. Arch Ophthalmol. 2007;125(9):1225–32.

    Article  PubMed  CAS  Google Scholar 

  54. SanGiovanni JP, Agron E, Meleth AD, et al. Omega-3 long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the Age-Related Eye Disease Study. Am J Clin Nutr. 2009;90(6):1601–7.

    Article  PubMed  CAS  Google Scholar 

  55. Tan JS, Wang JJ, Flood V, et al. Dietary fatty acids and the 10-year incidence of age-related macular degeneration: the Blue Mountains Eye Study. Arch Ophthalmol. 2009;127(5):656–65.

    Article  PubMed  CAS  Google Scholar 

  56. Augood C, Chakravarthy U, Young I, et al. Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration. Am J Clin Nutr. 2008;88(2):398–406.

    PubMed  CAS  Google Scholar 

  57. Christen WG, Schaumberg DA, Glynn R, et al. Dietary omega-3 fatty acid and fish intake and incident age-related macular degeneration in women. Arch Ophthalmol. 2011;129(7):921–9.

    Article  PubMed  Google Scholar 

  58. Ho L, van Leeuwen R, Witteman JCM, et al. Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and omega-3 fatty acids: the Rotterdam study. Arch Ophthalmol. 2011;129(6):758–66.

    Article  PubMed  CAS  Google Scholar 

  59. SanGiovanni JP, Chew EY. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res. 2005;24(1):87–138.

    Article  PubMed  CAS  Google Scholar 

  60. Chiu CJ, Klein R, Milton RC, et al. Does eating particular diets alter the risk of age-related macular degeneration in users of the Age-Related Eye Disease Study supplements? Br J Ophthalmol. 2009;93(9):1241–6.

    Article  PubMed  Google Scholar 

  61. Chiu CJ, Klein R, Milton RC, et al. Dietary compound score and risk of age-related macular degeneration in the age-related eye disease study. Ophthalmology. 2009;116(5):939–46.

    Article  PubMed  Google Scholar 

  62. Bazan NG. Homeostatic regulation of photoreceptor cell integrity: significance of the potent mediator neuroprotectin D1 biosynthesized from docosahexaenoic acid: the Proctor Lecture. Invest Ophthalmol Vis Sci. 2007;48(11):4866–81.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ocular Nutrition Society, Encinitas, CA, USA

    Jeffrey Anshel BS, OD

Authors
  1. Jeffrey Anshel BS, OD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jeffrey Anshel BS, OD .

Editor information

Editors and Affiliations

  1. DMF Ltd Company, Luxembourg Str 46, Marche/Famenne, 6900, Belgium

    Fabien De Meester PhD

  2. Health Sciences Center, Department of Health Promotion Sciences, University of Arizona, 1295 N. Martin Ave. 1295, Tucson, 85724-5155, Arizona, USA

    Ronald Ross Watson PhD

  3. Division of Health Promotion Sciences, Mel and Enid Zuckerman College of Public Health, University of Arizona, 1295 N. Martin Avenue, Tucson, 85724, Arizona, USA

    Sherma Zibadi PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Anshel, J. (2013). DHA, EPA, and Ocular Health. In: De Meester, F., Watson, R., Zibadi, S. (eds) Omega-6/3 Fatty Acids. Nutrition and Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-215-5_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-215-5_7

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-214-8

  • Online ISBN: 978-1-62703-215-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation